TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35091445 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study 35091462 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35091711 — Surrogate Endpoint (SUR): Pathological complete response
Study 35092506 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35093147 — Predictive Biomarker (PRD): TTK mRNA
Genes: TTK; MPS1; MPS1L1
Study 35093163 — Predictive Biomarker (PRD): SHANK3 mRNA
Genes: SHANK3; KIAA1650; PROSAP2; PSAP2
Study 35094066 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35094747 — Surrogate Endpoint (SUR): Blood pressure
Study 35095867 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35095867 — Predictive Biomarker (PRD): FCGR3A
Genes: CD16; CD16a; FcgammaRIIIa; FcGRIIIA
Study 35098170 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35098345 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35098345 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 35099394 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35099678 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35100339 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 35100339 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35100339 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 35100339 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35100459 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 35100692 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 35100692 — Predictive Biomarker (PRD): Hormone receptor
Study 35100692 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 35100697 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 35101049 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 35101049 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study 35101049 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study 35101049 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35101049 — Predictive Biomarker (PRD): MDK mRNA
Genes: MDK; MK1; NEGF2
Study 35101049 — Safety Biomarker (SAF): Hypoxanthine-guanine phosphoribosyltransferase
Genes: HPRT1; HPRT
Study 35101175 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35101941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35101941 — Predictive Biomarker (PRD): Microsatellite instability
Study 35101941 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35102064 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 35102497 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35103064 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35103064 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35105339 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study 35105709 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 35105939 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 35105939 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 35105939 — Predictive Biomarker (PRD): PTPRF mRNA
Genes: PTPRF; LAR
Study 35105939 — Predictive Biomarker (PRD): MBTPS1 mRNA
Genes: MBTPS1; KIAA0091; S1P; SKI1
Study 35106698 — Predictive Biomarker (PRD): PEX16 mRNA
Genes: PEX16
Study 35106962 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35107750 — Surrogate Endpoint (SUR): Blood pressure
Study 35107821 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35107848 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35107848 — Monitoring Biomarker (MOI): HBV DNA
Study 35108379 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35108379 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 35108395 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study 35108395 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study 35109669 — Safety Biomarker (SAF): Reactive oxygen species
Study 35109911 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 35110356 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35110356 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35110417 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 35110417 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 35110417 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 35110417 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study 35110690 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 35110690 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 35111398 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 35112307 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35112307 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35112343 — Predictive Biomarker (PRD): BBS10 mRNA
Genes: BBS10; C12orf58
Study 35112343 — Predictive Biomarker (PRD): SDCCAG8 mRNA
Genes: SDCCAG8; CCCAP; NPHP10; HSPC085
Study 35112343 — Predictive Biomarker (PRD): TTC21B mRNA
Genes: TTC21B; IFT139; KIAA1992; Nbla10696
Study 35112976 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 35113285 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35113812 — Surrogate Endpoint (SUR): Bone mineral density
Study 35113934 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35114739 — Surrogate Endpoint (SUR): Blood pressure
Study 35114807 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35115085 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35115085 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 35115167 — Predictive Biomarker (PRD): FMR1 mRNA
Genes: FMR1
Study 35115195 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35115306 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 35115306 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35115306 — Predictive Biomarker (PRD): Hepatitis A virus cellular receptor 2
Genes: HAVCR2; TIM3; TIMD3
Study 35115610 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 35116390 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 35118821 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study 35118915 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 35119530 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35120446 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35121899 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35121899 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35121950 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35122060 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35122700 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 35122700 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35122700 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35122700 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 35122700 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35122700 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35123074 — Predictive Biomarker (PRD): CDHR3 mRNA
Genes: CDHR3; CDH28
Study 35123074 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35123460 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35123544 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study 35123640 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35125401 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35125401 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35126362 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35126524 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35127744 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35128529 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35128529 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 35129146 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 35129214 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 35129317 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 35129317 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 35129317 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35129407 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 35129407 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 35129803 — Predictive Biomarker (PRD): LGI1 mRNA
Genes: LGI1; EPT; UNQ775/PRO1569
Study 35130417 — Predictive Biomarker (PRD): Hormone receptor
Study 35130943 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 35131031 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35131040 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35131040 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 35131254 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 35131254 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35131835 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35132679 — Monitoring Biomarker (MOI): Macrophage inflammatory protein 1-alpha
Genes: CCL3; G0S19-1; MIP1A; SCYA3
Study 35132704 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 35133982 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 35134880 — Safety Biomarker (SAF): Bacteroidetes phylum
Study 35135470 — Predictive Biomarker (PRD): KLRC2 mRNA
Genes: KLRC2; NKG2C
Study 35135644 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 35135810 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 35135832 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35136603 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35138325 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35138325 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 35138325 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35138474 — Surrogate Endpoint (SUR): Blood pressure
Study 35138474 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35138529 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35138529 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35139264 — Predictive Biomarker (PRD): RANGAP1 mRNA
Genes: RANGAP1; KIAA1835; SD
Study 35141170 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 35141170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35141572 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 35143011 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 35143771 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35143771 — Predictive Biomarker (PRD): RANGAP1 mRNA
Genes: RANGAP1; KIAA1835; SD
Study 35144742 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 35144742 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 35144742 — Predictive Biomarker (PRD): SCAI mRNA
Genes: SCAI; C9orf126
Study 35144789 — Surrogate Endpoint (SUR): Blood pressure
Study 35144802 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 35144802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35145218 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 35145478 — Predictive Biomarker (PRD): ANGPTL8 mRNA
Genes: ANGPTL8; C19orf80; RIFL; UNQ599/PRO1185
Study 35145638 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 35145638 — Surrogate Endpoint (SUR): Serum creatinine
Study 35146146 — Surrogate Endpoint (SUR): Serum creatinine
Study 35147501 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 35147794 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35148417 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35148417 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35149207 — Surrogate Endpoint (SUR): Blood pressure
Study 35149587 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study 35149587 — Predictive Biomarker (PRD): IL24 mRNA
Genes: IL24; MDA7; ST16
Study 35149587 — Safety Biomarker (SAF): Reactive oxygen species
Study 35149591 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 35149871 — Predictive Biomarker (PRD): REG1B mRNA
Genes: REG1B; PSPS2; REGL
Study 35151584 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study 35151584 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35152886 — Predictive Biomarker (PRD): SH2D1A mRNA
Genes: SH2D1A; DSHP; SAP
Study 35153091 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35154388 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35154389 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35154704 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35154704 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35155592 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35155592 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35155982 — Surrogate Endpoint (SUR): Blood pressure
Study 35156036 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35156195 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35156451 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35156709 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 35157306 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35157769 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35157769 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35158924 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 35160005 — Monitoring Biomarker (MOI): Procalcitonin
Study 35164745 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35165100 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35165100 — Predictive Biomarker (PRD): MAPK10 mRNA
Genes: MAPK10; JNK3; JNK3A; PRKM10; SAPK1B
Study 35165100 — Predictive Biomarker (PRD): INSR mRNA
Genes: INSR
Study 35165100 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study 35165421 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35165764 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 35166065 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 35166065 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study 35166465 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 35167051 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35167329 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 35167655 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35167866 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 35167907 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 35167972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35168547 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35168565 — Predictive Biomarker (PRD): SLC25A3 mRNA
Genes: SLC25A3; PHC; OK/SW-cl.48
Study 35169140 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 35170026 — Surrogate Endpoint (SUR): Blood pressure
Study 35171213 — Surrogate Endpoint (SUR): Blood pressure
Study 35171350 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 35171350 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35171350 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 35171350 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 35171350 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35171350 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 35172272 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35172272 — Predictive Biomarker (PRD): Hormone receptor
Study 35172272 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 35172286 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 35172518 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 35173290 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35173720 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 35173817 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35174220 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 35174220 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 35174366 — Safety Biomarker (SAF): RFC1
Genes: A1; PO-GA; RFC140; MHCBFB
Study 35174366 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 35174462 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35174749 — Surrogate Endpoint (SUR): Blood pressure
Study 35175229 — Surrogate Endpoint (SUR): Blood pressure
Study 35175355 — Predictive Biomarker (PRD): SLC5A5 mRNA
Genes: SLC5A5; NIS
Study 35175355 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35175355 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35175691 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 35175691 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35176401 — Predictive Biomarker (PRD): MAP4K2 mRNA
Genes: MAP4K2; GCK; RAB8IP
Study 35176457 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 35176488 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 35176488 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 35176764 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 35177415 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 35177415 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 35180296 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 35180323 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35180771 — Monitoring Biomarker (MOI): Angiopoietin 1 receptor
Genes: TEK; TIE2; VMCM; VMCM1
Study 35180771 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 35180771 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study 35180771 — Predictive Biomarker (PRD): PECAM1 mRNA
Genes: PECAM1
Study 35180771 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 11
Genes: CXCL11; ITAC; SCYB11; SCYB9B
Study 35180771 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 35180771 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35181498 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35181499 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35181499 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35181666 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL